clopidogrel has been researched along with Hematochezia in 221 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.45) | 18.2507 |
| 2000's | 48 (21.72) | 29.6817 |
| 2010's | 148 (66.97) | 24.3611 |
| 2020's | 24 (10.86) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, D; Cui, M; Deng, J; Feng, J; Gao, W; Han, Y; Huang, Y; Jia, S; Jiang, C; Li, J; Li, Y; Li, Z; Liao, Z; Ma, S; Ma, Y; Qiu, M; Qu, P; Ru, L; Sheng, J; Stone, GW; Tao, L; Wang, B; Wang, J; Wang, X; Yang, K; Yang, S; Yang, Y; Zhang, W; Zhao, X | 1 |
| Fan, X; Jiao, L; Ma, H; Meng, X; Wang, J; Zhao, L | 1 |
| Inaba, Y; Inoue, T; Kitahara, H; Kobayashi, Y; Shiko, Y; Tateishi, K | 1 |
| Huang, HY; Katz, AJ; Lin, FJ; Lin, SY; Sheu, JJ; Wang, CC; Wu, CH | 1 |
| Al-Hindi, L; Dai, J; Hedayati, SS; Jain, N; Martin, BC; Mehta, JL; Phadnis, MA; Rasu, RS; Shireman, TI | 1 |
| Huang, J; Liao, F; Shu, X; Tang, J | 1 |
| Je, NK; Lee, YJ | 1 |
| Chan, L; Chen, YC; Hsu, CY; Hu, CJ; Lin, CL; Muo, CH; Vidyanti, AN; Wu, D | 1 |
| Mooney, AP; Price, JM; Thomason, J; Whittemore, JC | 1 |
| Bestari, MB; Joewono, IR | 1 |
| Álvarez-Antón, S; Carballeira, D; Concepción, R; Dejuán-Bitriá, C; Del Castillo, H; Delgado-Calva, FA; López-Soberón, E; Marschall, A; Martí, D; Morales, MJ; Palazuelos, J; Pérez-Guzmán, J | 1 |
| Fukuta, H; Hagiwara, H; Ishizawa, K; Kamiya, T; Kimura, K; Niimura, T; Ohte, N; Zamami, Y | 1 |
| Ben-Dor, I; Chen, Y; Gajanana, D; Iantorno, M; Khalid, N; Khan, JM; Kolm, P; Musallam, A; Rogers, T; Satler, LF; Shlofmitz, E; Torguson, R; Waksman, R; Weintraub, WS; Zhang, C | 1 |
| Ayoub, F; Sengupta, N | 1 |
| Abraham, NS; Herrin, J; Inselman, J; Ngufor, C; Noseworthy, PA; Sangaralingham, LR; Shah, ND; Yang, EH; Yao, X | 1 |
| Zimmer, V | 1 |
| Bao, D; Han, X; Han, Y; Li, J; Li, Y; Li, Z; Liao, Z; Stone, GW; Wang, H; Wang, X; Xu, K | 1 |
| Balusson, F; Bouget, J; Lacut, K; Oger, E; Pavageau, L; Roy, PM; Viglino, D | 1 |
| Ai, H; Liu, R; Zhang, YJ; Zhao, XD; Zheng, W | 1 |
| Disney, BR; McFarlane, M | 1 |
| Bultas, J | 1 |
| Zhao, J | 1 |
| Byeon, JS; Choe, J; Hwang, SW; Kim, GU; Lee, S; Myung, SJ; Park, SH; Yang, DH; Yang, SK; Ye, BD | 1 |
| Deng, B; He, W; Lin, Y; Nie, R; Shu, X; Wang, J; Wu, X; Zhou, Z; Zhu, E | 1 |
| Fukuda, K; Shiratori, Y | 1 |
| Agudo-Fernández, S; Calvo Morillas, I; Castaño Milla, C; González Blanco, A; Olmos Jerez, JA; Sancho Del Val, L | 1 |
| Chen, WC; Chuah, SK; Hsu, PI; Huang, YT; Lin, KH; Sun, WC; Tsai, TJ; Wu, DC | 1 |
| Bang, CS; Hong, KS; Hong, MK; Jeong, H; Jung, MH; Kim, CY; Park, SM | 1 |
| Anuwatworn, A; Kumar, V; Petrasko, M; Stys, A; Yee, J | 1 |
| Chai, HT; Chang, HW; Chen, CJ; Chen, KH; Chua, S; Chung, SY; Lee, WC; Liu, CF; Sung, PH; Tong, MS; Yip, HK | 1 |
| Doan, G; Kaltenbach, T; Lin, D; McQuaid, K; Mou, S; Pham, C; Rouse, RV; Shergill, AK; Soetikno, RM; Somsouk, M | 1 |
| Alexander, E; Dawn, B; Gupta, K; Olyaee, M; Shaukat, A; Waheed, S; Washko, D | 1 |
| Bilker, WB; Brensinger, CM; Grosser, T; Hennessy, S; Kasner, SE; Leonard, CE; Li, X; Nam, YH | 1 |
| Chang, TY; Fan, PY; Hsieh, MY; Kuo, CF; Lee, CC; Li, IJ; Liu, SH; Tian, YC; Tu, KH; Weng, CH; Wu, HH; Yang, CW | 1 |
| Bhattacharya, J; Chang, M; Kaltenbach, T; Limketkai, BN; Lin, J; Oliver, M; Soetikno, R; Yu, JX | 1 |
| Chan, EW; Chen, L; Cheung, KS; Guo, CG; Isshiki, T; Leung, WK; Wong, ICK | 1 |
| Chiang, CH; Huang, WC; Hung, CC; Kuo, FY; Liang, HL; Lin, KC; Liu, CP; Mar, GY; Tang, PL; Wang, MT; Yang, JS | 1 |
| Amano, Y; Harada, H; Hayasaka, K; Katsuyama, Y; Murakami, D; Nagasaka, T; Nakahara, R; Sagami, R; Suehiro, S; Ujihara, T | 1 |
| Barsan, W; Easton, JD; Elm, JJ; Farrant, M; Johnston, SC; Kim, AS; Lindblad, AS; Palesch, YY; Tillman, H | 1 |
| Ahn, JH; Bae, JS; Hwang, JY; Hwang, SJ; Jang, JY; Jeong, YH; Kang, MG; Kim, KH; Koh, JS; Kwak, CH; Park, JR; Park, Y | 1 |
| Bilker, WB; Brensinger, CM; Cohen, JB; Hennessy, S; Leonard, CE; Nam, YH; Pham Nguyen, TP; Soprano, SE; Zhou, M | 1 |
| Hofma, S; Hoogendoorn, M; Kruik-Kollöffel, W; Oortgiesen, B; van der Elst, K; van Roon, E | 1 |
| Hauge, J; Kragh, R; Poulsen, BK | 1 |
| Abdel Samie, A; Theilmann, L | 1 |
| Amagase, K; Hara, D; Murakami, T; Takeuchi, K; Yoshida, Y | 1 |
| Duan, Z; Hu, K; Jiang, Z; Wang, Z; Wu, H; Ye, F; Zhang, Z | 1 |
| Gerson, LB | 1 |
| Baron, TH; Kamath, PS; McBane, RD | 1 |
| Asai, S; Nakayama, T; Nishida, Y; Takahashi, Y | 1 |
| Can, MM; Dinicolantonio, JJ; Kuliczkowski, W; Pershukov, IV; Serebruany, VL | 1 |
| Ahmed, JM; Badar, A; Bagnall, AJ; Edwards, RJ; Egred, M; Keavney, BD; Purcell, IF; Robinson, SD; Scaife, J; Spyridopoulos, I; Yan, AT; Zaman, AG | 1 |
| Edogawa, S; Harada, S; Higuchi, K; Kojima, Y; Ota, K; Takeuchi, T; Tokioka, S; Umegaki, E | 1 |
| Grove, EL; Würtz, M | 3 |
| Misro, AK; Pal, A; Sheth, H | 1 |
| Hou, MC; Hu, HY; Lee, FY; Lin, CC; Lin, HC; Luo, JC; Peng, YL | 1 |
| Asiimwe, A; Benoit, K; Delisle, F; Heath, L; Li, JJ; Motsko, S; Vangerow, H; Weerakkody, G; Wernicke, J | 1 |
| Cuschieri, JR; Drawz, P; Falck-Ytter, Y; Wong, RC | 1 |
| Chintala, M; Keohane, C; Li, Q; Ni, W; O'Neill, K; Shang, J; Wang, M; Wei, H | 1 |
| Martin, JB; Morneau, KM; Oliphant, CS; Reaves, AB | 1 |
| Cheng, VE; Haikerwal, D; Natarajan, D; Oppermen, A; Pereira, J | 1 |
| Chen, G; Du, Y; Hang, L; Ma, B | 1 |
| Fukui, H; Hida, N; Hori, K; Miwa, H; Nakamura, S; Ogawa, T; Ohda, Y; Okugawa, T; Oshima, T; Tomita, T; Tozawa, K; Watari, J | 1 |
| Furuta, T; Sugimoto, M; Uotani, T | 1 |
| Lagergren, J; Ljung, R; Lu, Y; Wang, Q | 1 |
| Fujikawa, T; Fukuyama, K; Kuramitsu, S; Tanaka, A | 1 |
| Chilton, R; Johnson, DA; Liker, HR | 1 |
| Akiyama, J; Aoki, T; Kishida, Y; Mizokami, M; Nagata, N; Niikura, R; Okubo, H; Sakurai, T; Sekine, K; Shimbo, T; Tanaka, S; Uemura, N; Watanabe, K; Yanase, M; Yokoi, C | 1 |
| Burke, DT; Lee, J | 1 |
| Ahn, DG; Kim, BJ; Kim, JG; Kim, JW | 1 |
| González-Pérez, A; Johansson, S; Nagy, P; Rodríguez, LA; Sáez, ME | 1 |
| Chen, SC; Rineer, J; Schreiber, D; Schwartz, D; Telivala, T; Worth, M | 1 |
| Amagase, K; Hashimoto, E; Itayama, M; Izuhara, C; Takayama, S; Takeuchi, K | 1 |
| Akiyama, J; Aoki, T; Moriyasu, S; Nagata, N; Niikura, R; Okubo, H; Sakurai, T; Sekine, K; Shimbo, T; Uemura, N; Watanabe, K; Yanase, M; Yokoi, C | 1 |
| Abe, J; Hara, H; Kinosada, Y; Miyamura, N; Nakamura, M; Nishibata, Y; Sekiya, Y; Suzuki, H; Suzuki, Y; Tsuchiya, T; Umetsu, R; Uranishi, H | 1 |
| Bhatt, DL; Cannon, CP; Cohen, M; Cryer, BL; Doros, G; Goldsmith, MA; Laine, L; Lanas, A; Lapuerta, P; Liu, Y; McIntosh, AI; Schnitzer, TJ; Vardi, M | 1 |
| Ford, NF | 1 |
| Chen, W; Wang, Y | 1 |
| Hirten, R; Inamdar, S; Sejpal, DV; Slattery, E; Trindade, AJ | 1 |
| Cahoon, WD; Francis, KE; Lowe, DK; Magee, LC; Oswalt, AK | 1 |
| Bhatt, DL; Cannon, CP; Cohen, M; Cryer, BL; Doros, G; Goldsmith, MA; Hsieh, WH; Laine, L; Lanas, A; Lapuerta, P; Liu, Y; Schnitzer, TJ; Shook, TL; Vaduganathan, M | 2 |
| Ayub, A; Hamid, S; Jafri, W; Khan, AH; Murtaza, D; Naeem, B; Parkash, O | 1 |
| Sha, WH; Tan, GY; Wang, QY; Zhang, ZF | 1 |
| Adler, DG; Jex, KT; Nicaud, MJ; Raines, DL | 1 |
| García Rodríguez, LA; Hennekens, CH; Lanas, A; Martín-Pérez, M; Rothwell, PM | 1 |
| Chao, Y; Chen, CC; Chen, TJ; Hu, YW; Huang, YH; Huo, TI; Lee, PC; Lin, HC; Liu, CJ; Su, CW; Wu, JC; Yeh, CM | 1 |
| García Rodríguez, LA; González-Pérez, A; Himmelmann, A; Johansson, S; Sáez, ME | 1 |
| Baker, BA; Cohen, DJ; Effron, MB; Faries, DE; Jackson, LR; Ju, C; McCoy, LA; Messenger, JC; Peterson, ED; Wang, TY; Zettler, M | 1 |
| García Rodríguez, LA; González-Pérez, A; Johansson, S; Nagy, P; Sáez, ME | 1 |
| Bykov, K; Choudhry, NK; Dong, YH; Donneyong, MM; Gagne, JJ; Schneeweiss, S | 1 |
| López-Higueras, A; Martínez-Andrés, B; Pérez-Cuadrado-Martínez, E; Pérez-Cuadrado-Robles, E; Quesada-Vázquez, N; Rubio-Mateos, JM; Sánchez-Melgarejo, JF | 1 |
| Goh, KL; Zou, D | 1 |
| Chang, CM; Chu, WM; Lam, KF; Lau, YK; Ng, FH; Wong, BC; Wong, SY; Yuen, WC | 1 |
| Chan, P; Cheung, TK; Kng, C; Kwanching, CP; Lai, ST; Loo, CK; Ng, FH; Ng, KM; Wong, BC; Wong, SY | 1 |
| Ameneiros-Lago, E; Fernández-Fernández, FJ; Martínez-Calvo, L; Sesma, P | 1 |
| Gorard, DA; Wysota, BA | 1 |
| Abraham, NS; Antman, EM; Bates, ER; Bhatt, DL; Bridges, CR; Chan, FK; Eisenberg, MJ; Ferrari, VA; Furberg, CD; Harrington, RA; Hlatky, MA; Johnson, DA; Kaul, S; Lindner, JR; Mahaffey, KW; Moliterno, DJ; Mukherjee, D; Quigley, EM; Rosenson, RS; Scheiman, J; Schofield, RS; Stein, JH; Weitz, HH; Wesley, DJ | 1 |
| Lane, DA; Lip, GY; Tay, KH | 1 |
| de Boer, A; Klungel, OH; Schalekamp, T; Souverein, PC | 1 |
| Lanas, A; Nardulli, G | 1 |
| Aronow, HD; Berger, PB; Brennan, DM; Steinhubl, SR; Topol, EJ | 1 |
| Moayyedi, P; Sadowski, DC | 1 |
| Cryer, B | 1 |
| Bredenoord, AJ; ten Berg, JM; van Werkum, JW | 1 |
| Angiolillo, DJ; Ferreiro, JL | 1 |
| Serebruany, VL | 1 |
| Barada, K; Dakik, HA | 1 |
| Luo, JC | 1 |
| Ayoubi, KZ; Cannon, MD; Doherty, GA; Harewood, GC; Lynch, KM; Murray, FE; Patchett, SE | 1 |
| Alessi, MC; Bali, L; Bonnet, JL; Cayla, G; Cuisset, T; Frere, C; Gaborit, B; Morange, PE; Poyet, R; Quilici, J | 1 |
| Bertrand, ME; Cox, DA; Dangas, GD; Fahy, M; Feit, F; Kirtane, AJ; Lansky, AJ; Lincoff, AM; Manoukian, SV; McLaurin, B; Mehran, R; Moses, JW; Nikolsky, E; Ohman, EM; Stone, GW; White, HD | 1 |
| Asano, F; Endo, Y; Inoue, K; Sawada, S; Takeyama, Y; Yamada, M; Yasuda, H; Yoshiba, M | 1 |
| Chang, PY; Chen, PF; Hsiao, FY; Huang, WF; Kuo, KN; Tsai, YW; Wen, YW | 1 |
| Furuta, T | 1 |
| Hennekens, C; Laine, L | 1 |
| Bretagne, JF | 1 |
| Howard, PA; Vacek, JL | 1 |
| Choudhary, S; Joshi, R; Kohli, V; Sibal, A | 1 |
| Herszényi, L; Juhász, M; Tulassay, Z | 1 |
| Bond, JH; McDougall, H; Nelson, DB; Sawhney, MS | 1 |
| Ben-Dor, I; Collins, SD; Delhaye, C; Gaglia, MA; Gonzalez, MA; Hanna, N; Kent, KM; Maluenda, G; Pichard, AD; Satler, LF; Suddath, WO; Syed, AI; Torguson, R; Wakabayashi, K; Waksman, R; Xue, Z | 1 |
| Jezovnik, MK; Poredos, P | 1 |
| Arif, A; Kaul, V; Mehta, N; Murthy, UK; Newman, N; Singh, M | 1 |
| Chung, CP; Daugherty, JR; Griffin, MR; Hall, K; Kaltenbach, LA; Murray, KT; Ray, WA; Smalley, WE; Stein, CM | 1 |
| Griswold, ME; Localio, AR; Mulrow, C | 1 |
| Gaglia, MA; Waksman, R | 1 |
| Oyetayo, OO; Talbert, RL | 1 |
| McCarthy, DM | 1 |
| Bereznicki, L; Luinstra, M; Naunton, M; Peterson, GM | 1 |
| Mourad, JJ | 1 |
| Gratsianskiĭ, NA | 1 |
| Hunt, RH; Tan, VP; Wong, BC; Yan, BP | 1 |
| Aisenberg, J; Bamji, ND; Bodian, CA; Cohen, LB; Desai, JC; Dikman, AE; Harpaz, N; Kornacki, S; Miller, KM; Sanyal, S; von Althann, C; Whitson, MJ | 1 |
| Chen, PF; Hsiao, FY; Huang, WF; Kuo, KN; Tsai, YW; Wen, YW | 1 |
| Christ, G; Huber, K; Jilma, B; Schrör, K; Siller-Matula, JM | 1 |
| Marcucci, R | 1 |
| Bhatt, DL; Cannon, CP; Cohen, M; Contant, CF; Cryer, BL; Goldsmith, MA; Laine, L; Lanas, A; Lapuerta, P; Murphy, SA; Schnitzer, TJ; Scirica, BM; Shook, TL | 1 |
| Abraham, NS; Antman, EM; Bhatt, DL; Bjorkman, DJ; Clark, CB; Furberg, CD; Hlatky, MA; Johnson, DA; Kahi, CJ; Laine, L; Mahaffey, KW; Quigley, EM; Scheiman, J; Sperling, LS; Tomaselli, GF | 2 |
| Southworth, MR; Temple, R | 1 |
| Lettino, M | 1 |
| Fujita, M; Haruma, K; Honda, K; Ishii, M; Kamada, T; Matsumoto, H; Murao, T; Sakakibara, T; Shiotani, A; Tarumi, K | 1 |
| Chubachi, H; Ikee, R; Miyasaka, Y; Saito, S; Yasu, T | 1 |
| Amorós, S; Fernández-Sender, L; Marsal, J; Martínez-Cerezo, FJ; Pascual, D; Tena, FJ | 1 |
| Branzi, A; De Palma, R; Marino, M; Marzocchi, A; Ortolani, P | 1 |
| Arakawa, T; Fujiwara, Y; Machida, H; Nadatani, Y; Okazaki, H; Otani, K; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamagami, H | 1 |
| Hamm, CW; Rassaf, T | 1 |
| Arramraju, S; John, BK; Rubin, M; Shalomov, A; Sison, C | 1 |
| Juurlink, DN | 1 |
| Ford, AC; Sadek, A | 1 |
| García Rodríguez, LA; Hernández-Díaz, S; Johansson, S; Lin, KJ | 1 |
| Heyrosa, MG; Khubchandani, IT; Thekkeurumbil, SV | 1 |
| Ben-Menachem, T; Dominitz, JA | 1 |
| Ferraccioli, GF; Gremese, E; Laria, A; Zoli, A | 1 |
| Gurbel, PA; Kereiakes, DJ; Tantry, US | 1 |
| Kim, JH | 1 |
| Bae, SE; Jung, HK; Jung, SA; Kim, SE; Kim, TH; Moon, IH; Shim, KN; Yoo, K; Yoon, SY | 1 |
| Chang, CM; Cheng, JJ; Chiu, CZ; Chua, SK; Hung, HF; Kuan, P; Lee, SH; Liao, CS; Lin, SC; Liou, JY; Lo, HM; Shyu, KG | 1 |
| Hernández-Romero, D; Jover, E; Lip, GY; Marín, F; Muñoz-Esparza, C; Saura, D; Valdés, M | 1 |
| Hughes, JD; Lee, YP; Parsons, R; Shrestha, K | 1 |
| Henry, ZH; Northup, PG; Patrie, JT; Peura, DA; Pop, GH; Regan, KA; Richter, JA; Richter, RP; Sawyer, RG; Wang, AY | 1 |
| Bhalodkar, NC; Loganathan, J; Mehta, A; Mehta, D; Paladugu, N | 1 |
| Boot, H; de Boer, A; Deneer, VH; Harmsze, AM; Heringa, M; le Comte, M; Mol, PG; Schalekamp, T; Verduijn, MM; Verheugt, FW | 1 |
| Banerjee, A; Bhala, N; Rajasekhar, P; Taggar, JS | 1 |
| Amariles, P; Ceballos, M; Holguín, H | 1 |
| Howden, CW; Leontiadis, GI; Yuan, Y | 1 |
| Abraham, NS | 1 |
| Almadi, MA; Barkun, A; Brophy, J | 1 |
| Harrison, RW; Mahaffey, KW | 1 |
| Eskind, L; Gulati, S; Montegudo, A; Narang, T; Pierson, J; Russo, MW | 1 |
| Chan, K; Chu, WM; Keung, KK; Kng, C; Kwan, A; Lam, KF; Lau, YK; Li, A; Ng, FH; Tunggal, P; Wong, BC | 1 |
| Ahmed, SA; Bonham, AJ; Clarkston, WK; Laya, AS; Singh, D; Vaidya, OU | 1 |
| Barthélémy, O; Bellemain-Appaix, A; Beygui, F; Brieger, D; Collet, JP; Costagliola, D; Lancar, R; Mercadier, A; Montalescot, G; Silvain, J | 1 |
| Chen, J; Howden, CW; Leontiadis, GI; Yuan, YC | 1 |
| Aihara, H; Akiyama, D; Aonuma, K; Hoshi, T; Kakefuda, Y; Nishina, H; Sato, A; Takeyasu, N; Watabe, H | 1 |
| Hsu, PI | 1 |
| Kwok, CS; Loke, YK | 1 |
| Bueno, H; Cea Soriano, L; García Rodríguez, LA; Johansson, S | 1 |
| Banerjee, S; Brilakis, ES; Little, BB; Mohammad, A; Weideman, RA | 1 |
| Postma, DF; Struijk, M; van de Ree, MA; van Tuyl, SA | 1 |
| Hashimoto, E; Izuhara, C; Kaneko, S; Takayama, S; Takeuchi, K; Yamada, N; Yamanaka, S | 1 |
| Ammann, P; Borovicka, J; Haile, SR; Häuptle, R; Knellwolf, C; Schneider, T; Weilenmann, D | 1 |
| Drepper, MD; Frossard, JL; Spahr, L | 1 |
| Chmiel, A; Gąsior, Z; Gieszczyk, K; Haberka, M; Kunecki, M; Kyrcz-Krzemień, S; Lasota, B; Mizia, M; Mizia-Stec, K; Najda, J | 1 |
| Dworzynski, K; Higgins, B; Kelsey, A; Palmer, K; Pollit, V | 1 |
| Grove, EL; Jørgensen, NR; Schwarz, P; Vestergaard, P; Würtz, M | 1 |
| Ament, PW; Dicola, DB; James, ME | 1 |
| Fujikawa, T; Maekawa, H; Shiraishi, K; Tanaka, A | 1 |
| Chan, FK; Goh, KL; Mahadeva, S; Menon, J; Ng, WK; Tan, HJ; Zainal Abidin, I | 1 |
| Chan, HH; Chang, SN; Hsiao, SH; Hsu, PI; Huang, HR; Lai, KH; Lin, CH; Lin, CK; Lin, KH; Liu, CP; Tsai, TJ; Tsay, FW; Wang, HM; Wang, KM; Yu, HC | 1 |
| Andrade, C | 1 |
| Chang, FY; Chen, TS; Hou, MC; Huang, CC; Huang, KW; Lee, FY; Leu, HB; Lin, HC; Lu, CL; Luo, JC | 1 |
| Chang, CM; Chen, WH; Kng, C; Lanas, AI; Ng, FH; Wong, BC; Wong, SY | 1 |
| Ching, JY; Chung, SC; Hui, AJ; Hung, LC; Sung, JJ; Wong, RM | 1 |
| Jacobs, AK; Wolk, MJ | 1 |
| Pedersen, FM; Schaffalitzky de Muckadell, OB | 1 |
| Archimandritis, A; Cokkinos, D; Elisaf, MS; Kiskinis, D; Liberopoulos, EN; Mikhailidis, DP; Tselepis, AD | 1 |
| Angerson, WJ; Blatchford, O; Knill-Jones, RP; Taha, AS | 1 |
| Bhala, N; Taggar, J | 1 |
| Choi, L; Crowell, MD; Jones, MP; Kaplan, M; Keshavarzian, A; Lau, C; Sharp, L; Wessinger, S; Williams, M | 1 |
| Harder, S; Hohlfeld, T; Weber, AA | 1 |
| Johansen, M | 1 |
| Arnesen, Ø; Riis, JS | 1 |
| Coufal, Z; Kojecký, V | 1 |
| Dunning, J; Hooper, T; Hoschtitzky, A; Ziegelin, M | 1 |
| Brophy, JM; Delaney, JA; Opatrny, L; Suissa, S | 1 |
| Johnson, DA | 1 |
| Cannon, CP; Laine, L; Murphy, SA; Schreiner, GC | 1 |
| Chang, CM; Chu, WM; Lam, KF; Lau, YK; Ng, FH; Wong, BC; Wong, SY | 1 |
| Ben Eli, M; Elias, S; Hauptman, E; Katz, MG; Sasson, L; Shimonov, M | 1 |
| Good, DE | 1 |
| Boon, NA; Henriksen, PA; Palmer, K | 1 |
| Ackman, ML; Gellatly, RM | 1 |
| Delaney, JA; Opatrny, L; Suissa, S | 1 |
| Arnout, J; Cariou, R; De Schepper, PJ; Depré, M; van Hecken, A; Vanbilloen, H; Vanhove, P; Verbruggen, A; Wynants, K | 1 |
| Albertson, CM; Fink, LM; Hauer-Jensen, M; Herbert, JM; Wang, J; Zheng, H | 1 |
51 review(s) available for clopidogrel and Hematochezia
| Article | Year |
|---|---|
Aspirin vs. P2Y12 Inhibitor Rivalry: Which One Can be Continued During Gastrointestinal Bleeding.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists; Secondary Prevention; Societies, Medical; Stroke | 2019 |
A Primer on Bleeding Risk and Management Strategies of Newer Oral Anti Platelet Agents in Cardiovascular Disease.
Topics: Adenosine; Administration, Oral; Aspirin; Cardiovascular Diseases; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Thrombosis; Ticagrelor; Ticlopidine | 2016 |
Systematic review with meta-analysis: the risk of gastrointestinal bleeding in patients taking third-generation P2Y
Topics: Clopidogrel; Gastrointestinal Hemorrhage; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Ticagrelor | 2019 |
[Proton pump inhibitors when using clopidogrel: balance between necessity and disadvantages].
Topics: Aspirin; Clopidogrel; Drug Interactions; Female; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors | 2019 |
Endoscopic procedures in patients under clopidogrel/dual antiplatelet therapy: to do or not to do?
Topics: Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrhage; Humans; Intestinal Polyps; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Ticlopidine | 2013 |
Proton pump inhibitors and potential interactions with clopidogrel: an update.
Topics: Cardiovascular Diseases; Clopidogrel; Confounding Factors, Epidemiologic; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2013 |
New anticoagulant and antiplatelet agents: a primer for the gastroenterologist.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cholangiopancreatography, Endoscopic Retrograde; Clopidogrel; Dabigatran; Drug Interactions; Fondaparinux; Gastrointestinal Hemorrhage; Humans; Piperazines; Platelet Aggregation Inhibitors; Polysaccharides; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine | 2014 |
[Oral antiplatelet agents can still be used along with proton pump inhibitors in spite of drug interactions].
Topics: Adenosine; Administration, Oral; Aspirin; Clopidogrel; Cyclooxygenase Inhibitors; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Piperazines; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Factors; Thienopyridines; Thiophenes; Ticagrelor; Ticlopidine | 2013 |
Clopidogrel and Genotyping.
Topics: Acute Coronary Syndrome; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Genotype; Humans; Omeprazole; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Stents; Ticlopidine | 2015 |
Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Evidence-Based Medicine; Gastrointestinal Hemorrhage; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Public Health; Secondary Prevention; Stroke; Ticlopidine | 2015 |
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Clopidogrel; Databases, Factual; Gastrointestinal Hemorrhage; Humans; Incidence; Intracranial Hemorrhages; Observational Studies as Topic; Odds Ratio; Risk; Ticlopidine | 2016 |
Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs.
Topics: Adenosine; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Administration Schedule; Drug Dosage Calculations; Drug Interactions; Esomeprazole; Gastrointestinal Hemorrhage; Gene Expression; Humans; Hydrogen-Ion Concentration; Peptic Ulcer; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic Antagonists; Receptors, Purinergic P2Y12; Ticagrelor; Ticlopidine | 2017 |
East Asian perspective on the interaction between proton pump inhibitors and clopidogrel.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anticoagulants; Asia, Eastern; Asian People; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Dexlansoprazole; Drug Interactions; Drug Therapy, Combination; Gastroesophageal Reflux; Gastrointestinal Hemorrhage; Humans; Isoenzymes; Pantoprazole; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Ticlopidine | 2017 |
[Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprostone; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Middle Aged; Misoprostol; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Thromboxanes; Ticlopidine | 2009 |
Management of patients with high gastrointestinal risk on antiplatelet therapy.
Topics: Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Risk Factors; Thiophenes; Ticlopidine | 2009 |
Aggressive chronic platelet inhibition with prasugrel and increased cancer risks: revising oral antiplatelet regimens?
Topics: Animals; Aspirin; Clopidogrel; Colonic Neoplasms; Gastrointestinal Hemorrhage; Humans; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Thiophenes; Ticlopidine | 2009 |
Proton pump inhibitor and clopidogrel interaction: fact or fiction?
Topics: Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine | 2010 |
[Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aspirin; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Lansoprazole; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine | 2009 |
Gastrointestinal bleed with clopidogrel and aspirin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2010 |
Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Gastroenterology; Gastrointestinal Hemorrhage; Humans; Myocardial Infarction; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Recurrence; Ticlopidine | 2010 |
Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
Topics: Administration, Oral; Aspirin; Cardiovascular Diseases; Clopidogrel; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Treatment Outcome | 2010 |
Proton pump inhibitors and clopidogrel.
Topics: Aryl Hydrocarbon Hydroxylases; Biotransformation; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Evidence-Based Medicine; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Assessment; Ticlopidine | 2010 |
Proton pump inhibitors and clopidogrel: is it a significant drug interaction?
Topics: Blood Platelets; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 2010 |
[Antiplatelet therapy in coronary heart disease. Some problems and achivements].
Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Aspirin; Blood Platelets; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Resistance; Gastrointestinal Hemorrhage; Humans; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Genetic; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Receptor, PAR-1; Thiophenes; Ticagrelor; Ticlopidine; United States; United States Food and Drug Administration | 2010 |
Proton pump inhibitor and clopidogrel interaction: the case for watchful waiting.
Topics: Algorithms; Clopidogrel; Drug Interactions; Evidence-Based Medicine; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Ticlopidine | 2010 |
Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Prognosis; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 2010 |
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Aspirin; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Factors; Thienopyridines; Thiophenes; Ticlopidine | 2010 |
Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
Topics: Acute Coronary Syndrome; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Thrombosis; Ticlopidine | 2010 |
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Aspirin; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Factors; Thienopyridines; Thiophenes; Ticlopidine | 2010 |
Gastrointestinal bleeding after percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Intestines; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2011 |
[Coronary heart disease - what is of importance after coronary intervention?].
Topics: Adenosine; Aftercare; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Drug-Eluting Stents; Gastrointestinal Hemorrhage; Humans; Myocardial Revascularization; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Proton Pump Inhibitors; Stents; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections.
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Aspirin; Calcium, Dietary; Clopidogrel; Clostridioides difficile; Comorbidity; Cytochrome P-450 CYP2C19; Disease Susceptibility; Drug Interactions; Enterocolitis, Pseudomembranous; Fractures, Spontaneous; Gastrointestinal Hemorrhage; Humans; Hyperparathyroidism, Secondary; Infections; Osteoporosis; Proton Pump Inhibitors; Rheumatic Diseases; Risk; Thrombophilia; Ticlopidine | 2011 |
Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations.
Topics: Animals; Biotransformation; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Evidence-Based Medicine; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Ticlopidine | 2011 |
Interactions between clopidogrel and proton pump inhibitors: a review of evidence.
Topics: Clopidogrel; Drug Interactions; Drug Resistance; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Ticlopidine | 2011 |
Clopidogrel with proton pump inhibitors: safe or not?
Topics: Cardiovascular Diseases; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Assessment; Ticlopidine | 2011 |
[Interaction between clopidogrel and proton pump inhibitors].
Topics: Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2011 |
Anticipating and managing bleeding complications in patients with coronary stents who are receiving dual antiplatelet treatment.
Topics: Blood Component Transfusion; Catheters, Indwelling; Clopidogrel; Coagulants; Coronary Artery Disease; Coronary Restenosis; Drug Interactions; Drug Therapy, Combination; Drug-Eluting Stents; Endoscopy, Gastrointestinal; Fibrinolytic Agents; Forecasting; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stents; Ticlopidine; Treatment Outcome | 2011 |
The interaction between proton pump inhibitors and clopidogrel and upper gastrointestinal bleeding.
Topics: Cardiovascular Diseases; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine; Upper Gastrointestinal Tract | 2011 |
Prescribing proton pump inhibitor and clopidogrel together: current state of recommendations.
Topics: Clopidogrel; Drug Interactions; Drug Prescriptions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Ticlopidine | 2011 |
Clopidogrel and PPI interaction: clinically relevant or not?
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Thienopyridines; Ticlopidine | 2012 |
Recent safety concerns with proton pump inhibitors.
Topics: Clopidogrel; Drug Interactions; Drug Therapy, Combination; Fractures, Spontaneous; Gastrointestinal Hemorrhage; Humans; Hypercalciuria; Nephrocalcinosis; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Renal Tubular Transport, Inborn Errors; Risk Factors; Ticlopidine; Treatment Outcome | 2012 |
Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors.
Topics: Animals; Blood Platelets; Clopidogrel; Drug Interactions; Evidence-Based Medicine; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Ticlopidine | 2012 |
The clinical relevance of the clopidogrel-proton pump inhibitor interaction.
Topics: Animals; Biotransformation; Clopidogrel; Cytochrome P-450 Enzyme System; Drug Interactions; Evidence-Based Medicine; Gastrointestinal Hemorrhage; Genotype; Humans; Phenotype; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Ticlopidine | 2012 |
Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Ticlopidine | 2012 |
Clopidogrel and proton pump inhibitors--where do we stand in 2012?
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Aspirin; Biotransformation; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Ticlopidine | 2012 |
Reducing adverse effects of proton pump inhibitors.
Topics: Anemia, Iron-Deficiency; Clopidogrel; Clostridioides difficile; Critical Care; Diarrhea; Drug Interactions; Enterocolitis, Pseudomembranous; Gastroesophageal Reflux; Gastrointestinal Hemorrhage; Hip Fractures; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pneumonia; Proton Pump Inhibitors; Recurrence; Risk Factors; Stomach Ulcer; Stress, Physiological; Ticlopidine; Ulcer | 2012 |
Drug interactions in the treatment of depression in patients with ischemic heart disease.
Topics: Aged; Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Comorbidity; Cytochrome P-450 CYP2C19; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Early Diagnosis; Fluoxetine; Fluvoxamine; Gastrointestinal Hemorrhage; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ticlopidine | 2012 |
Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?
Topics: Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2006 |
Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic, antiinflammatory drugs? Arguments against.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Cardiovascular Diseases; Clopidogrel; Cyclooxygenase 2 Inhibitors; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Patient Selection; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Thrombosis; Ticlopidine | 2006 |
Does clopidogrel rather than aspirin plus a proton-pump inhibitor reduce the frequency of gastrointestinal complications after cardiac surgery?
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Drug Therapy, Combination; Evidence-Based Medicine; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Platelet Aggregation Inhibitors; Postoperative Complications; Proton Pump Inhibitors; Ticlopidine | 2007 |
Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cardiology; Cardiovascular Diseases; Clopidogrel; Dose-Response Relationship, Drug; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Humans; Patient Selection; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stomach Ulcer; Ticlopidine | 2005 |
19 trial(s) available for clopidogrel and Hematochezia
| Article | Year |
|---|---|
Magnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-Induced Gastrointestinal Injury.
Topics: Aged; Aspirin; Capsule Endoscopy; Clopidogrel; Dual Anti-Platelet Therapy; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ulcer | 2022 |
Time of Resumption of Antiplatelet Drugs After Upper Gastrointestinal Hemorrhage.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2022 |
Clinical, clinicopathologic, and gastrointestinal changes from administration of clopidogrel, prednisone, or combination in healthy dogs: A double-blind randomized trial.
Topics: Animals; Clopidogrel; Dogs; Double-Blind Method; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Glucocorticoids; Platelet Aggregation Inhibitors; Prednisone; Stomach Ulcer | 2019 |
Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: Rationale and design of the OPT-PEACE trial.
Topics: Adult; Aspirin; Capsule Endoscopy; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Female; Gastrointestinal Hemorrhage; Humans; Male; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Adjustment | 2020 |
Rationale and Design for a Randomized Comparison of Efficacy and Safety between Aspirin and Clopidogrel in Atrial Fibrillation Patients with Low Stroke Risk: CESAC-AF trial.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Endoscopy, Digestive System; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Research Design; Risk Factors; Stroke; Ticlopidine | 2017 |
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hematuria; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Secondary Prevention; Severity of Illness Index; Stroke | 2019 |
Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting.
Topics: Angiography; Aspirin; Breath Tests; Carotid Arteries; Carotid Stenosis; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Stents; Ticlopidine | 2013 |
A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel.
Topics: Adult; Alanine; Anti-Ulcer Agents; Aspirin; Clopidogrel; Double-Blind Method; Gastric Mucosa; Gastrointestinal Hemorrhage; Healthy Volunteers; Humans; Male; Peptic Ulcer; Platelet Aggregation Inhibitors; Quinolones; Ticlopidine; Young Adult | 2014 |
The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine; Young Adult | 2015 |
Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
Topics: Aged; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspepsia; Female; Gastrointestinal Hemorrhage; Humans; Intestinal Obstruction; Intestinal Perforation; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Omeprazole; Pain; Peptic Ulcer; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Stroke; Ticlopidine | 2016 |
Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Omeprazole; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome | 2016 |
Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors | 2009 |
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Topics: Acute Coronary Syndrome; Age Factors; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Clopidogrel; Coronary Artery Bypass; Female; Gastrointestinal Hemorrhage; Heparin; Hirudins; Humans; Incidence; Ischemia; Length of Stay; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Risk Assessment; Sex Factors; Stents; Thrombosis; Ticlopidine | 2009 |
Is gastroduodenal biopsy safe in patients receiving aspirin and clopidogrel?: a prospective, randomized study involving 630 biopsies.
Topics: Adult; Aspirin; Biopsy; Clopidogrel; Duodenum; Endoscopy, Digestive System; Female; Gastrointestinal Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Pyloric Antrum; Risk Factors; Single-Blind Method; Ticlopidine | 2011 |
Clopidogrel with or without omeprazole in coronary artery disease.
Topics: Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2010 |
Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction.
Topics: Acute Coronary Syndrome; Aged; Anti-Ulcer Agents; Aspirin; Chi-Square Distribution; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Esomeprazole; Famotidine; Female; Fibrinolytic Agents; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intestinal Perforation; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Ticlopidine; Treatment Outcome | 2012 |
Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Angina, Stable; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Stents; Ticlopidine; Treatment Outcome | 2012 |
Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Proton Pump Inhibitors; Risk Factors; Ticlopidine; Treatment Outcome; Warfarin | 2007 |
Effect of clopidogrel on naproxen-induced gastrointestinal blood loss in healthy volunteers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Bleeding Time; Clopidogrel; Double-Blind Method; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Male; Naproxen; Occult Blood; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 1998 |
151 other study(ies) available for clopidogrel and Hematochezia
| Article | Year |
|---|---|
Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention.
Topics: Anticoagulants; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Ischemic Stroke; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Treatment Outcome | 2022 |
Effectiveness and Safety of Clopidogrel vs Aspirin in Elderly Patients With Ischemic Stroke.
Topics: Aged; Aspirin; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Stroke; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Secondary Prevention; Stroke; Treatment Outcome | 2022 |
Age Modifies Intracranial and Gastrointestinal Bleeding Risk from P2Y
Topics: Aged; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Kidney Failure, Chronic; Middle Aged; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Renal Dialysis; Retrospective Studies; Ticagrelor | 2022 |
Risk factors for gastrointestinal bleeding in patients with cerebral infarction after dual antiplatelet therapy.
Topics: Aspirin; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Hypertension; Peptic Ulcer; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine | 2023 |
Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke.
Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hemorrhagic Stroke; Humans; Ischemic Stroke; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Secondary Prevention; Stroke; Treatment Outcome | 2023 |
Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study.
Topics: Aged; Aspirin; Brain Ischemia; Cardiovascular Diseases; Cerebral Hemorrhage; Clopidogrel; Female; Gastrointestinal Hemorrhage; Humans; Male; Propensity Score; Retrospective Studies; Stroke | 2019 |
Impact of Anemia on the Risk of Bleeding Following Percutaneous Coronary Interventions in Patients ≥75 Years of Age.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anemia; Angina, Unstable; Anticoagulants; Antithrombins; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Artery Disease; Drug-Eluting Stents; Female; Gastrointestinal Hemorrhage; Hemorrhage; Heparin; Hirudins; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Myocardial Infarction; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Hemorrhage; Prasugrel Hydrochloride; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Risk Assessment; Stents; Ticagrelor; Urologic Diseases | 2020 |
Comparison of Hemorrhagic Risk between Prasugrel and Clopidogrel: a Retrospective Study using Adverse Drug Event Reporting Databases.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clinical Trials, Phase III as Topic; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists | 2020 |
Ischemic Versus Bleeding Outcomes After Percutaneous Coronary Interventions in Patients With High Bleeding Risk.
Topics: Aged; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Artery Disease; Dual Anti-Platelet Therapy; Female; Gastrointestinal Hemorrhage; Heart Failure; Hemorrhage; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prevalence; Renal Insufficiency; Risk; Risk Assessment; Stents; Thrombosis | 2020 |
Double Trouble: Reducing Gastrointestinal Bleeding due to DAPT Following Acute Coronary Syndromes.
Topics: Acute Coronary Syndrome; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2021 |
Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Cohort Studies; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Retrospective Studies; Thromboembolism; Ticagrelor; Treatment Outcome; United States | 2020 |
Cap-fitted identification and endoscopic haemostasis of a tiny vascular colonic lesion under maintained triple antithrombotic therapy.
Topics: Aspirin; Blood Transfusion; Clopidogrel; Colonic Diseases; Colonoscopy; Combined Modality Therapy; Drug Therapy, Combination; Endoscopy, Digestive System; Equipment Design; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; Ileocecal Valve; Male; Middle Aged; Reoperation; Thrombosis; Warfarin | 2021 |
Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Cohort Studies; Databases, Factual; Drug Therapy, Combination; Female; France; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Incidence; Intracranial Hemorrhages; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Young Adult | 2020 |
Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational cohort study (STROBE compliant).
Topics: Acute Coronary Syndrome; Aged; Clinical Decision Rules; Clopidogrel; Cohort Studies; Female; Gastrointestinal Hemorrhage; Heart Failure; Humans; Male; Middle Aged; Partial Thromboplastin Time; Peptic Ulcer; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Renal Insufficiency; Research Design; Risk Assessment | 2020 |
Editorial - out with the old and in with the new? Gastrointestinal bleeding risk of P2Y
Topics: Acute Coronary Syndrome; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Ticagrelor | 2020 |
Are proton pump inhibitors an effective and safe drug not only in the prophylaxis of gastrointestinal bleeding in antithrombotic treatment?
Topics: Aspirin; Clopidogrel; Drug Interactions; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Proton Pump Inhibitors | 2020 |
Letter: the risk of gastrointestinal bleeding in patients taking third-generation P2Y
Topics: Acute Coronary Syndrome; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Ticagrelor | 2020 |
Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel.
Topics: Administration, Oral; Aged; Anticoagulants; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Thromboembolism; Ticlopidine; Warfarin | 2021 |
Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease.
Topics: China; Clopidogrel; Coronary Artery Disease; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Bleeding Colonic Worm-Like Polyps.
Topics: Aged; Clopidogrel; Colonic Polyps; Colonoscopy; Diagnosis, Differential; Gastrointestinal Hemorrhage; Hemostasis, Surgical; Humans; Male; Platelet Aggregation Inhibitors | 2021 |
RHEDAR study: Determination of the risk of gastrointestinal hemorrhage in treatment with dabigatran, acenocoumarol and rivaroxaban.
Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Retrospective Studies; Rivaroxaban; Warfarin | 2021 |
The risk of lower gastrointestinal bleeding in low-dose aspirin users.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Clopidogrel; Comorbidity; Cyclooxygenase 2 Inhibitors; Databases, Factual; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Incidence; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Renal Insufficiency, Chronic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Taiwan; Ticlopidine; Warfarin; Young Adult | 2017 |
Impact of Double Loading Regimen of Clopidogrel on Final Angiographic Results, Incidence of Upper Gastrointestinal Bleeding and Clinical Outcomes in Patients with STEMI Undergoing Primary Coronary Intervention.
Topics: Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Graft Occlusion, Vascular; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; ST Elevation Myocardial Infarction; Survival Rate; Taiwan; Thrombolytic Therapy; Ticlopidine; Time Factors | 2017 |
Risk factors for postpolypectomy bleeding in patients receiving anticoagulation or antiplatelet medications.
Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Female; Gastrointestinal Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Thromboembolism; Ticlopidine; Time Factors; Warfarin | 2018 |
Etiology of gastrointestinal bleeding in patients on dual antiplatelet therapy.
Topics: Aged; Aspirin; Clopidogrel; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastroenteritis; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Severity of Illness Index; Ticlopidine | 2018 |
Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Clopidogrel; Drug Interactions; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Incidence; Intracranial Hemorrhages; Medicaid; Middle Aged; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Ticlopidine; United States; Young Adult | 2018 |
Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Vessel Prosthesis Implantation; Clopidogrel; Databases, Factual; Female; Gastrointestinal Hemorrhage; Graft Occlusion, Vascular; Humans; Intracranial Hemorrhages; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Factors; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Taiwan; Thrombosis; Treatment Failure; Warfarin; Young Adult | 2019 |
Patients Prescribed Direct-Acting Oral Anticoagulants Have Low Risk of Postpolypectomy Complications.
Topics: Aged; Anticoagulants; Case-Control Studies; Clopidogrel; Colonic Polyps; Colonoscopy; Endoscopic Mucosal Resection; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Stroke; Warfarin | 2019 |
Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study.
Topics: Aged; Case-Control Studies; Cerebral Hemorrhage; Clopidogrel; Dipyridamole; Disease-Free Survival; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Proportional Hazards Models; Secondary Prevention; Stroke; Survival Rate | 2019 |
Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Endoscopic Mucosal Resection; Feasibility Studies; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Stomach Neoplasms; Thrombosis; Treatment Outcome | 2019 |
Influence of rabeprazole and famotidine on pharmacodynamic profile of dual antiplatelet therapy in clopidogrel-sensitive patients: The randomized, prospective, PROTECT trial.
Topics: Aged; Clopidogrel; Drug Interactions; Famotidine; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Rabeprazole; Randomized Controlled Trials as Topic | 2020 |
Clopidogrel Drug Interactions and Serious Bleeding: Generating Real-World Evidence via Automated High-Throughput Pharmacoepidemiologic Screening.
Topics: Aged; Aged, 80 and over; Clopidogrel; Databases, Factual; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Pharmacoepidemiology; Platelet Aggregation Inhibitors | 2019 |
[Gastrointestinal bleeding after treatment with ticagrelor].
Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Coronary Artery Bypass; Female; Gastrointestinal Hemorrhage; Humans; Pulmonary Disease, Chronic Obstructive; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine; Treatment Outcome | 2013 |
Prophylactic effect of egualen sodium, a stable azulene derivative, on gastrointestinal damage induced by ischemia/reperfusion, double antiplatelet therapy and loxoprofen in rats.
Topics: Animals; Aspirin; Azulenes; Benzoquinones; Clopidogrel; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastrointestinal Tract; Heptanoic Acids; Male; Mice; Mice, Inbred C57BL; Mucus; Nitric Oxide Synthase Type II; Peptic Ulcer; Peroxidase; Phenylpropionates; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sesquiterpenes; Ticlopidine | 2013 |
Proton-pump inhibitors can decrease gastrointestinal bleeding after percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Age Factors; Aged; Alcohol Drinking; Angina, Stable; Aspirin; Case-Control Studies; Clopidogrel; Female; Gastrointestinal Hemorrhage; Humans; Male; Peptic Ulcer; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Sex Factors; Smoking; Ticlopidine | 2013 |
Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study.
Topics: Aged; Aspirin; Biomarkers; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hematologic Tests; Humans; Japan; Leukocytes; Linear Models; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Propensity Score; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Chemical and Drug Induced Liver Injury; Clinical Trials, Phase III as Topic; Clopidogrel; Double-Blind Method; Female; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Factors; Thiophenes; Ticagrelor; Ticlopidine | 2013 |
Provision of gastroprotective medication and bleeding risk following acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Clopidogrel; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Treatment Outcome | 2013 |
The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection.
Topics: Adenoma; Aged; Anti-Ulcer Agents; Anticoagulants; Aspirin; Carcinoma; Case-Control Studies; Clopidogrel; Dissection; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Stomach Diseases; Stomach Neoplasms; Stomach Ulcer; Thienopyridines; Ticlopidine; Warfarin | 2013 |
Endoscopic biopsy on patients taking antiplatelet agents: how much do we follow BSG, ASGE or ESGE guidelines?
Topics: Aspirin; Biopsy; Clopidogrel; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrhage; Humans; Physicians; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Professional Practice; Risk; Surveys and Questionnaires; Ticlopidine | 2014 |
Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Cohort Studies; Databases, Factual; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Proportional Hazards Models; Regression Analysis; Renal Insufficiency, Chronic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Taiwan; Ticlopidine | 2013 |
Diagnoses of gastrointestinal cancers after gastrointestinal bleeding in patients receiving clopidogrel or warfarin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Cohort Studies; Female; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Ticlopidine; Time Factors; Warfarin; Young Adult | 2013 |
Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel.
Topics: Acute Disease; Age Factors; Aged; Anticoagulants; Chronic Disease; Clopidogrel; Female; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Ohio; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Veterans; Warfarin | 2014 |
A novel approach to assess the spontaneous gastrointestinal bleeding risk of antithrombotic agents using Apc(min/+) mice.
Topics: Age Factors; Animals; Benzimidazoles; Clopidogrel; Dabigatran; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Genes, APC; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Pyrazoles; Pyridines; Pyridones; Risk Factors; Ticlopidine; Warfarin | 2014 |
Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Guideline Adherence; Hospitalization; Humans; Male; Middle Aged; Patient Readmission; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome | 2014 |
Spontaneous omental bleeding in the setting of dual anti-platelet therapy with ticagrelor.
Topics: Adenosine; Aged; Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine | 2014 |
Does rebamipide prevent gastric mucosal injury in patients taking aspirin and clopidogrel?
Topics: Alanine; Anti-Ulcer Agents; Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Quinolones; Ticlopidine | 2014 |
Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Peptic Ulcer; Platelet Aggregation Inhibitors; Prognosis; Proton Pump Inhibitors; Risk; Sweden; Ticlopidine | 2014 |
Successful treatment of bleeding large duodenal gastrointestinal stromal tumour in a patient under dual antiplatelet therapy after recent drug-eluting coronary stent implantation.
Topics: Aged; Aspirin; Benzamides; Chemotherapy, Adjuvant; Clopidogrel; Coronary Stenosis; Drug-Eluting Stents; Duodenal Neoplasms; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Hemostatic Techniques; Humans; Imatinib Mesylate; Male; Neoadjuvant Therapy; Piperazines; Platelet Aggregation Inhibitors; Pyrimidines; Ticlopidine | 2014 |
Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.
Topics: Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Antagonism; Drug Labeling; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Ticlopidine; United States; United States Food and Drug Administration | 2014 |
Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Clopidogrel; Colonic Diseases; Colonoscopy; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Rectal Diseases; Risk Factors; Ticlopidine | 2014 |
Lower gastrointestinal bleeding associated with diclofenac topical patch in a patient with colonic mass and on antiplatelet therapy for atrial fibrillation.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Atrial Fibrillation; Clopidogrel; Colonic Neoplasms; Colonoscopy; Diclofenac; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Myofascial Pain Syndromes; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Transdermal Patch | 2014 |
[Clinical impact of dual antiplatelet therapy on peptic ulcer disease].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Proportional Hazards Models; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine | 2014 |
Patterns of Antiplatelet Therapy in Patients Who Have Experienced an Acute Coronary Event: A Descriptive Study in UK Primary Care.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Cohort Studies; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Health Care; Proton Pump Inhibitors; Retrospective Studies; Secondary Prevention; Stroke; Ticlopidine; United Kingdom | 2015 |
Assessment of risk of late rectal bleeding for patients with prostate cancer started on anticoagulation before or after radiation treatment.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectum; Retrospective Studies; Risk; Telangiectasis; Ticlopidine; Warfarin | 2014 |
Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats.
Topics: Alanine; Animals; Anti-Ulcer Agents; Aspirin; Clopidogrel; Disease Models, Animal; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Male; Platelet Aggregation Inhibitors; Quinolones; Rats, Sprague-Dawley; Stomach Ulcer; Ticlopidine; Treatment Outcome | 2014 |
Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Ticlopidine; Warfarin; Young Adult | 2015 |
Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database.
Topics: Adverse Drug Reaction Reporting Systems; Aspirin; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Embolism; Female; Gastrointestinal Hemorrhage; Humans; Male; Odds Ratio; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Thrombosis; Ticlopidine; United States; United States Food and Drug Administration | 2015 |
Endoscopic ultrasound-guided fine-needle aspiration of solid lesions on clopidogrel may not be a high-risk procedure for bleeding: A case series.
Topics: Aged; Clopidogrel; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endoscopy, Gastrointestinal; Endosonography; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Thrombosis; Ticlopidine | 2016 |
Cangrelor Bridge Therapy for Gastroduodenal Biopsy.
Topics: Adenosine Monophosphate; Administration, Intravenous; Biopsy; Clopidogrel; Female; Gastrointestinal Hemorrhage; Humans; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine | 2017 |
Proton pump inhibitors and other disease-based factors in the recurrence of adverse cardiovascular events following percutaneous coronary angiography: A long-term cohort.
Topics: Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk; Ticlopidine; Time Factors | 2016 |
[The incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding in patients taking dual antiplatelet therapy after percutaneous coronary intervention in south China].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; China; Clopidogrel; Coronary Artery Disease; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Peptic Ulcer; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine; Upper Gastrointestinal Tract | 2016 |
Pharmacologic provocation combined with endoscopy in refractory cases of GI bleeding.
Topics: Aged; Aged, 80 and over; Anticoagulants; Balloon Enteroscopy; Clopidogrel; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Rivaroxaban; Ticlopidine; Vascular Malformations | 2017 |
Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection.
Topics: Adult; Aged; Aspirin; Carcinoma, Hepatocellular; Clopidogrel; Disease-Free Survival; Female; Gastrointestinal Hemorrhage; Hepatectomy; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Survival Rate; Taiwan; Ticlopidine | 2016 |
Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Clopidogrel; Confidence Intervals; Coronary Artery Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hospitalization; Humans; Incidence; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Survival Rate; Ticlopidine; United Kingdom | 2016 |
Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acu
Topics: Acute Coronary Syndrome; Aftercare; Aged; Cardiovascular Diseases; Clopidogrel; Comparative Effectiveness Research; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proportional Hazards Models; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Recurrence; Stroke; Ticlopidine; Treatment Outcome | 2016 |
Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Health Care; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sex Factors; Ticlopidine; Time Factors; United Kingdom | 2017 |
Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors.
Topics: Aged; Cerebral Hemorrhage; Clopidogrel; Cohort Studies; Cytochrome P-450 CYP2C19 Inhibitors; Databases, Factual; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Stroke; Ticlopidine | 2017 |
Nonsteroidal anti-inflammatory drugs-induced small bowel enteropathy and obscure gastrointestinal bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Capsule Endoscopy; Case-Control Studies; Clopidogrel; Comorbidity; Coronary Disease; Female; Gastrointestinal Hemorrhage; Humans; Intestinal Diseases; Logistic Models; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine | 2018 |
Upper gastrointestinal bleeding in patients with aspirin and clopidogrel co-therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Myocardial Ischemia; Odds Ratio; Platelet Aggregation Inhibitors; Ticlopidine | 2008 |
Management and outcome of peptic ulcers or erosions in patients receiving a combination of aspirin plus clopidogrel.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Disease; Female; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Hospitalization; Humans; Male; Peptic Ulcer; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2008 |
[Upper gastrointestinal bleeding associated with clopidogrel and paroxetine].
Topics: Aged; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Male; Paroxetine; Platelet Aggregation Inhibitors; Selective Serotonin Reuptake Inhibitors; Ticlopidine | 2008 |
Colonic carcinoma unmasked by dual antiplatelet therapy.
Topics: Aspirin; Clopidogrel; Colonic Neoplasms; Female; Gastrointestinal Hemorrhage; Humans; Incidental Findings; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine | 2008 |
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Platelet Aggregation Inhibitors; Risk Factors; Societies, Medical; Ticlopidine; United States | 2008 |
Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin?
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Coagulation; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Platelet Aggregation Inhibitors; Registries; Risk Assessment; Risk Factors; Ticlopidine; Warfarin | 2008 |
Effect of oral antiplatelet agents on major bleeding in users of coumarins.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Logistic Models; Male; Medical Records Systems, Computerized; Middle Aged; Netherlands; Odds Ratio; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Vitamin K | 2008 |
Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?
Topics: Aspirin; Clopidogrel; Cytochrome P-450 Enzyme System; Data Interpretation, Statistical; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Ticlopidine | 2009 |
Proton pump inhibitors and clopidogrel: a difficult dilemma.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Thrombosis; Ticlopidine | 2009 |
Antiplatelet therapy: Clopidogrel plus PPIs-a dangerous combination?
Topics: Acute Coronary Syndrome; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Secondary Prevention; Ticlopidine; Treatment Outcome | 2009 |
Adverse outcomes associated with use of proton pump inhibitors and clopidogrel.
Topics: Acute Coronary Syndrome; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk; Ticlopidine | 2009 |
Aspirin for heart attack, stroke prevention. When benefits outweigh risks: four new studies help clarify who should--and who shouldn't--take the drug.
Topics: Aspirin; Clopidogrel; Contraindications; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine | 2009 |
Gastroprotective strategy in aspirin users.
Topics: Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors; Ticlopidine | 2009 |
Co-prescription of gastro-protectants in hospitalized patients: an analysis of what we do and what we think we do.
Topics: Aged; Aged, 80 and over; Aspirin; Attitude of Health Personnel; Clopidogrel; Data Collection; Female; Gastrointestinal Hemorrhage; Hospitals, Teaching; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Proton Pump Inhibitors; Risk Factors; Ticlopidine | 2010 |
Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Biomarkers; Cell Adhesion Molecules; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Microfilament Proteins; Middle Aged; Patient Discharge; Phosphoproteins; Phosphorylation; Pilot Projects; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Risk Assessment; Ticlopidine; Time Factors; Treatment Outcome | 2009 |
Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Disease; Drug Interactions; Drug Therapy, Combination; Drug-Eluting Stents; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome | 2009 |
A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Topics: Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Clopidogrel; Databases, Factual; Drug Costs; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Patient Readmission; Peptic Ulcer; Platelet Aggregation Inhibitors; Proportional Hazards Models; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Secondary Prevention; Taiwan; Ticlopidine | 2009 |
Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Ticlopidine | 2009 |
Potential Interaction between clopidogrel and proton pump inhibitors.
Topics: Acute Coronary Syndrome; Clopidogrel; Coronary Thrombosis; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome | 2009 |
Clinical trial update II: TRITON-TIMI 38 provides reassurance on concomitant use of proton pump inhibitors and thienopyridines.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Thiophenes; Ticlopidine | 2009 |
Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Colonic Neoplasms; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; Logistic Models; Male; Mass Screening; Middle Aged; Occult Blood; Odds Ratio; Platelet Aggregation Inhibitors; Predictive Value of Tests; Retrospective Studies; Ticlopidine; Unnecessary Procedures; Warfarin | 2010 |
Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug-Eluting Stents; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Survival Rate; Ticlopidine | 2010 |
Postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel therapy.
Topics: Aged; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; Logistic Models; Male; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Ticlopidine | 2010 |
Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
Topics: Adult; Aged; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Proton Pump Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Treatment Outcome | 2010 |
Propensity score adjustment with multilevel data: setting your sites on decreasing selection bias.
Topics: Cardiovascular Diseases; Clopidogrel; Data Interpretation, Statistical; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Platelet Aggregation Inhibitors; Propensity Score; Proportional Hazards Models; Proton Pump Inhibitors; Selection Bias; Ticlopidine | 2010 |
Probing the occult: testing for blood in the stools.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Colonic Neoplasms; Colonoscopy; Gastrointestinal Hemorrhage; Humans; Mass Screening; Occult Blood; Platelet Aggregation Inhibitors; Predictive Value of Tests; Ticlopidine; Unnecessary Procedures; Warfarin | 2010 |
PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Cohort Studies; Cross-Sectional Studies; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Northern Territory; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Tasmania; Ticlopidine; Young Adult | 2010 |
Withdrawal of clopidogrel in active gastric bleeding.
Topics: Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Platelet Aggregation Inhibitors; Research Design; Ticlopidine | 2010 |
Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Proportional Hazards Models; Proton Pump Inhibitors; Retrospective Studies; Risk; Taiwan; Ticlopidine; Treatment Outcome | 2011 |
[Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Myocardial Infarction; Myocardial Revascularization; Odds Ratio; Peptic Ulcer; Platelet Aggregation Inhibitors; Prognosis; Proton Pump Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Ticlopidine; Time Factors | 2010 |
Interaction of clopidogrel and omeprazole.
Topics: Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2010 |
Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury.
Topics: Aged; Aged, 80 and over; Aspirin; Capsule Endoscopy; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Pyridines; Retrospective Studies; Ticlopidine; Ulcer; Warfarin | 2011 |
[Efficacy and safety of concomitant use of rabeprazole during dual-antiplatelet therapy with clopidogrel and aspirin after drug-eluting stent implantation: a retrospective cohort study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Cohort Studies; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Interactions; Drug-Eluting Stents; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Ticlopidine; Treatment Outcome | 2010 |
Upper digestive bleeding due to Dieulafoy´s lesion during the postoperative period of aortocoronary bypass surgery in a patient treated with clopidogrel.
Topics: Aged; Arterioles; Clopidogrel; Coronary Artery Bypass; Gastrointestinal Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Stomach; Ticlopidine | 2010 |
In brief: Clopidogrel and omeprazole.
Topics: Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2010 |
One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Chi-Square Distribution; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Patient Readmission; Platelet Aggregation Inhibitors; Proportional Hazards Models; Proton Pump Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome | 2012 |
Antiplatelet agents do not impact the hospital course in patients with gastrointestinal bleeding.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Cohort Studies; Dizziness; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Young Adult | 2011 |
Clopidogrel with or without omeprazole in coronary disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Cardiovascular Diseases; Chemistry, Pharmaceutical; Clopidogrel; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2011 |
Clopidogrel with or without omeprazole in coronary disease.
Topics: Clopidogrel; Coronary Artery Disease; Cost-Benefit Analysis; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2011 |
Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk; Ticlopidine; United Kingdom | 2011 |
Optimal timing of anticoagulation pre- and post-colonoscopy with polypectomy.
Topics: Anticoagulants; Aspirin; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Postoperative Period; Retrospective Studies; Ticlopidine; Warfarin | 2011 |
Acute upper gastrointestinal hemorrhage in an elderly woman taking aspirin and clopidogrel.
Topics: Aged; Aspirin; Clopidogrel; Female; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2011 |
[Does combination therapy of aspirin plus antiplatelet therapy increase the risk of upper gastrointestinal hemorrhage?].
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2011 |
[The effect of aspirin alone or aspirin plus additional antiplatelets therapy on upper gastrointestinal hemorrhage].
Topics: Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine | 2011 |
Gastrointestinal bleeding and outcomes after percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Female; Gastrointestinal Hemorrhage; Heparin; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Taiwan; Ticlopidine; Treatment Outcome | 2011 |
The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Topics: Aged, 80 and over; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Drug Utilization Review; Female; Gastrointestinal Hemorrhage; Humans; Male; New South Wales; Nursing Homes; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Ticlopidine | 2011 |
Bleeding after percutaneous endoscopic gastrostomy is linked to serotonin reuptake inhibitors, not aspirin or clopidogrel.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Cohort Studies; Female; Gastrointestinal Hemorrhage; Gastroscopy; Gastrostomy; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Ticlopidine; Time Factors; Young Adult | 2011 |
[Clinical importance of the clopidogrel - omeprazole interaction: a question to solve].
Topics: Clopidogrel; Controlled Clinical Trials as Topic; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2012 |
Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: an 86-year-old woman with peptic ulcer disease.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine; Warfarin | 2011 |
Coronary artery stents and antiplatelet therapy in patients with cirrhosis.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Fatty Liver; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stents; Ticlopidine | 2012 |
Risk of bleeding after percutaneous endoscopic gastrostomy (PEG).
Topics: Aged; Anticoagulants; Clopidogrel; Female; Gastrointestinal Hemorrhage; Gastroscopy; Gastrostomy; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk Factors; Ticlopidine | 2012 |
Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center.
Topics: Abciximab; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Hemorrhage; Hospital Mortality; Humans; Immunoglobulin Fab Fragments; Incidence; Internet; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paris; Platelet Aggregation Inhibitors; Proportional Hazards Models; Radial Artery; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome | 2012 |
Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
Topics: Aged; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Propensity Score; Proportional Hazards Models; Proton Pump Inhibitors; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2012 |
New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Thiophenes; Ticlopidine | 2012 |
Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
Topics: Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine; Time Factors; United Kingdom | 2012 |
A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Clopidogrel; Drug Interactions; Famotidine; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Male; Omeprazole; Peroxidase; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Ticlopidine | 2012 |
Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study.
Topics: Acute Coronary Syndrome; Adrenal Cortex Hormones; Adverse Drug Reaction Reporting Systems; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Cohort Studies; Combined Modality Therapy; Coronary Angiography; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Peptic Ulcer; Platelet Aggregation Inhibitors; Precision Medicine; Proton Pump Inhibitors; Ticlopidine | 2012 |
Management of acute upper gastrointestinal bleeding: summary of NICE guidance.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Component Transfusion; Clopidogrel; Contraindications; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Resuscitation; Risk Assessment; Secondary Prevention; Terlipressin; Ticlopidine; United Kingdom; Vasoconstrictor Agents; Warfarin | 2012 |
Combining aspirin and proton pump inhibitors: for whom the warning bell tolls?
Topics: Aspirin; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2012 |
Gastrointestinal events with clopidogrel: a nationwide population-based cohort study.
Topics: Aged; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Denmark; Dose-Response Relationship, Drug; Drug Utilization; Female; Gastritis; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine | 2013 |
Successful resection of complicated bleeding arteriovenous malformation of the jejunum in patients starting dual-antiplatelet therapy just after implanting a drug-eluting coronary stent.
Topics: Arteriovenous Malformations; Aspirin; Clopidogrel; Drug-Eluting Stents; Gastrointestinal Hemorrhage; Humans; Jejunum; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine | 2012 |
Statements of the Malaysian Society of Gastroenterology & Hepatology and the National Heart Association of Malaysia task force 2012 working party on the use of antiplatelet therapy and proton pump inhibitors in the prevention of gastrointestinal bleeding.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Malaysia; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2013 |
Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Prospective Studies; Smoking; Ticlopidine | 2012 |
Risk factors for upper gastrointestinal bleeding in coronary artery disease patients receiving both aspirin and clopidogrel.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Artery Disease; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Risk Factors; Ticlopidine; Upper Gastrointestinal Tract | 2013 |
High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease.
Topics: Aged; Aspirin; Clopidogrel; Cohort Studies; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Longitudinal Studies; Male; Peptic Ulcer; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Ticlopidine | 2003 |
Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases.
Topics: Aged; Anticoagulants; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Ticlopidine; Warfarin | 2004 |
Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Proton Pump Inhibitors; Secondary Prevention; Ticlopidine | 2005 |
[Clopidogrel and upper gastrointestinal hemorrhage].
Topics: Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Ticlopidine | 2005 |
Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Esophagitis; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Hematemesis; Humans; Intestinal Mucosa; Male; Middle Aged; Platelet Aggregation Inhibitors; Stomach Ulcer; Ticlopidine; Warfarin | 2006 |
Clopidogrel and metoprolol in myocardial infarction.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Metoprolol; Myocardial Infarction; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine | 2006 |
Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Black or African American; Blood Coagulation; Case-Control Studies; Clopidogrel; Drug Interactions; Enoxaparin; Female; Gastrointestinal Hemorrhage; Hispanic or Latino; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ticlopidine; Warfarin; White People | 2006 |
[Antiplatelet therapy after aspirin-induced upper gastrointestinal bleeding].
Topics: Anti-Ulcer Agents; Aspirin; Clopidogrel; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Esomeprazole; Evidence-Based Medicine; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Ticlopidine | 2006 |
[Platelet inhibition and gastric problems].
Topics: Anti-Ulcer Agents; Aspirin; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Ticlopidine | 2007 |
[Clinically manifest gastrointestinal bleeding in patients subject to coronary angiography].
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Coronary Angiography; Duodenal Ulcer; Esophagitis; Female; Gastrointestinal Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Stomach Ulcer; Ticlopidine | 2007 |
Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2007 |
Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Enoxaparin; Female; Gastrointestinal Hemorrhage; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Statistics, Nonparametric; Ticlopidine | 2008 |
Portal vein thrombosis associated with coronary artery bypass surgery.
Topics: Aged; Aspirin; Bacteremia; Clopidogrel; Coagulase; Coronary Artery Bypass; Esophageal and Gastric Varices; Fatal Outcome; Gastrointestinal Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Portal Vein; Staphylococcus; Ticlopidine; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Venous Thrombosis | 2008 |
Combined antithrombotic therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2008 |
Management of upper gastrointestinal haemorrhage complicating dual anti-platelet therapy.
Topics: Aged; Aspirin; Blood Transfusion; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Platelet Count; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 2008 |
Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
Topics: Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Ticlopidine | 2008 |
Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antidepressive Agents; Case-Control Studies; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ticlopidine; Warfarin | 2008 |
Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine.
Topics: Adenosine Diphosphate; Animals; Chemotaxis, Leukocyte; Clopidogrel; Collagen; Endothelium, Vascular; Enteritis; Extracellular Matrix; Fibrosis; Gastrointestinal Hemorrhage; Intestine, Small; Male; Muscle, Smooth; Neutrophils; Platelet Aggregation; Platelet Aggregation Inhibitors; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ticlopidine; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |